News

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 6, 2021

News

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

Cell Therapies Pty Ltd interim CEO and Chief Scientific Officer A/Prof Dominic Wall has spoken…

Cell TherapiesMarch 5, 2021

News

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

Last week we announced the TGA approval for Cell Therapies to manufacture Novartis’ CAR-T therapy,…

Cell TherapiesFebruary 18, 2021

News

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Cell Therapies Pty Ltd, a contract manufacturing organisation located within the Peter MacCallum Cancer Centre,…

Cell TherapiesFebruary 11, 2021

News

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

The Board of Cell Therapies Pty Ltd (CTPL) has announced that Dr Dawn Driscoll will…

Cell TherapiesNovember 11, 2020

News

Better Diagnostic Technologies for Cancer Detection

Cell tracking case study “Better diagnostic technologies for cancer detection” has been published on the…

Cell TherapiesOctober 21, 2020

News

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre, in collaboration with RMIT University, the…

Cell TherapiesMay 29, 2020

News

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

While hospitals in many parts of the world have faced unprecedented challenges with routine clinical…

Cell TherapiesMay 28, 2020

News

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Health Minister Greg Hunt announces funding for Kymriah today at the Peter MacCallum Cancer Institute…

Cell TherapiesJanuary 28, 2020

News

Cell Therapies attending Phacilitate

Cell Therapies Pty Ltd will be attending the Phacilitate Leaders World Conference, part of Advanced…

Cell TherapiesDecember 2, 2019

News

Cell Therapies attending ISCT Paris

Cell Therapies Pty Ltd will be attending the International Society for Cell & Gene Therapy…

Cell TherapiesDecember 2, 2019

News

Cell Therapies Pty Ltd Becomes the First Australian Company Awarded a Commercial CAR-T TGA License

For the first time in Australia, Cell Therapies Pty Ltd (CTPL), a recognised leader in the…

Cell TherapiesAugust 29, 2019

Filter

Cell Therapies and Viral Vector Manufacturing Facility (VVMF) enters strategic collaboration

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

Cell Therapies to partner with Chimeric Therapeutics Ltd

News and Resources

The latest news and insights from Cell Therapies

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

Better Diagnostic Technologies for Cancer Detection

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Cell Therapies attending Phacilitate

Cell Therapies attending ISCT Paris

Cell Therapies Pty Ltd Becomes the First Australian Company Awarded a Commercial CAR-T TGA License

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate